United Kingdom · Funded startup

Who invested in AbOliGo

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechManufacturing

Funding summaryUpdated 15 Nov 2026

$2.0Mraised across 2 rounds since 2024, from 2 sources

$197KRound$1.8MRound
Latest round
Round, $1.8MJul 2025
Step-upi
9.3×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2025
$197KRound$1.8MRound
First round
Round, $197K
Oct 2024
Biggest round
$1.8M
Round · Jul 2025
Between rounds
9 months
from the last two

The rounds

  1. Jul 2025
    Round$1.8M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  2. Oct 2024
    Round$197K

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

Funding filed with regulators

AbOliGo filed 2 raises, $2.0M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Jul 2025$1.8MUK share allotment
  2. Oct 2024$197KUK share allotment

Founders and team

From AbOliGo's own website: 5 on the team.

  • Brian Carpenter Ph.D.CEO
  • Ed Ralph Ph.D.CTO
  • Mick KnowlesHead of Reagents
  • Nick Gee Ph.D.Non-Executive Director
  • Nick Hutchings D.Phil.Chairman

Quick answers about AbOliGo

How much has AbOliGo raised?

AbOliGo has raised $2.0M across 2 rounds since 2024.

When did AbOliGo last raise?

AbOliGo's most recent round, $1.8M, was in Jul 2025.

What was AbOliGo's biggest round?

Its most recent round, $1.8M in Jul 2025, is also its largest on record.

Where is AbOliGo based?

AbOliGo is based in the United Kingdom.

Companies like AbOliGo

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.